Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

202 Ghirardello A, Caponi L, Franceschini F, Zampieri S, Quinzanini M, Bendo R et al.
Diagnostic Tests for Antiribosomal P Protein Antibodies: A Comparative Evaluation of
Immunoblotting and ELISA Assays. J Autoimmun 2002; 19: 71–77.
203 Gillis JZ, Panopalis P, Schmajuk G, Ramsey-Goldman R, Yazdany J. Systematic review of
the literature informing the systemic lupus erythematosus indicators project: reproductive
health care quality indicators. Arthritis Care Res (Hoboken) 2011; 63: 17–30.
204 Shi W, Gordon S, Chesterman C, Krilis S, Chong B. Prevalence of lupus anticoagulant and
anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990; 20: 231–236.
205 Martinez-Berriotxoa A, Ruiz-irastorza G, Egurbide M, Garmendia M, Erdozain JG, Villar
I et al. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients
with systemic lupus erythematosus. Lupus 2007; 16: 810–816.
206 Otomo K, Atsumi T, Amengual O, Fujieda Y, Kato M, Oku K et al. Efficacy of the
antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive
value for thrombotic events. Arthritis Rheum 2012; 64: 504–512.
207 Tomer Y, Viegas O, Swissa M, Koh S, Shoenfeld Y. Levels of lupus autoantibodies in
pregnant SLE patients: correlations with disease activity and pregnancy outcome. Clin
Exp Rheumatol 1996; 14: 275–280.
208 Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and
treatment of couples with recurrent first-trimester and second-trimester miscarriage.
Royal College of Obstetricians and Gynaecologists: London (UK), 2011.
209 American College of Obstetricians and Gynecologists (ACOG). Antiphospholipid
syndrome. American College of Obstetricians and Gynecologists: Washington (DC), 2011.
210 Finnish Medical Society Duodecim. Blood transfusion: indications, administration and
adverse reactions. In: Wiley Interscience, John Wiley & Sons (eds). Evidence-Based
Medicine. Helsinki, Finland, 2008.
211 Sciascia S, Murru V, Sanna G, Roccatello D, Khamashta M a, Bertolaccini ML. Clinical
accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus:
evaluation of 23 possible combinations of antiphospholipid antibody specificities. J
Thromb Haemost 2012; 10: 2512–2518.
212 Sullivan K, Wisnieski J, Winkelstein J, Louie J, Sachs E, Choi R. Serum complement
determinaton in patients with quiescent systemic lupus erythematosus. J Rheumatol 1996;
23: 2063–2067.
213 Mollnes TE, Haga H, Brun JG, Nielsen EW, Bergh K, Sjo A et al. Complement activation
in patients with systemic lupus erythematosus without nephritis. Rheumatology 1999; 38:
933–940.
214 Amezcua-Guerra L, Springall R, Arrieta-Alvarado A, Rodríguez V, Rivera-Martinez E,
Castillo-Martinez D et al. C-reactive protein and complement components but not other
acute-phase reactants discriminate between clinical subsets and organ damage in systemic
lupus erythematosus. Clin Lab 2011; 57: 607–613.
450 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS